Does ENFORTUMAB VEDOTIN-EJFV Cause Therapy partial responder? 18 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 18 reports of Therapy partial responder have been filed in association with ENFORTUMAB VEDOTIN-EJFV. This represents 0.5% of all adverse event reports for ENFORTUMAB VEDOTIN-EJFV.
18
Reports of Therapy partial responder with ENFORTUMAB VEDOTIN-EJFV
0.5%
of all ENFORTUMAB VEDOTIN-EJFV reports
1
Deaths
3
Hospitalizations
How Dangerous Is Therapy partial responder From ENFORTUMAB VEDOTIN-EJFV?
Of the 18 reports, 1 (5.6%) resulted in death, 3 (16.7%) required hospitalization.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ENFORTUMAB VEDOTIN-EJFV. However, 18 reports have been filed with the FAERS database.
What Other Side Effects Does ENFORTUMAB VEDOTIN-EJFV Cause?
Rash (560)
Malignant neoplasm progression (410)
Neuropathy peripheral (410)
Fatigue (281)
Pruritus (260)
Diarrhoea (257)
Death (238)
Decreased appetite (230)
Off label use (193)
Alopecia (185)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which ENFORTUMAB VEDOTIN-EJFV Alternatives Have Lower Therapy partial responder Risk?
ENFORTUMAB VEDOTIN-EJFV vs ENFORTUMAB VEDOTIN\ENFORTUMAB VEDOTIN-EJFV
ENFORTUMAB VEDOTIN-EJFV vs ENFUVIRTIDE
ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN
ENFORTUMAB VEDOTIN-EJFV vs ENOXAPARIN - WINTHROP
ENFORTUMAB VEDOTIN-EJFV vs ENSIFENTRINE